Selective in Vivo Removal of Pathogenic Anti-Mag Autoantibodies, an Antigen-Specific Treatment Option for Anti-Mag Neuropathy

Proceedings of the National Academy of Sciences of the United States of America - United States

doi 10.1073/pnas.1619386114